Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver

Abstract Non-human primates (NHPs) represent the most valuable animals for drug discovery. However, the current main challenge remains that the NHP has not yet been used to develop an efficient translational medicine platform simulating human diseases, such as cancer. This study generated an in situ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liping Zhong, Yong Huang, Jian He, Nuo Yang, Banghao Xu, Yun Ma, Junjie Liu, Chao Tang, Chengpiao Luo, Pan Wu, Zongqiang Lai, Yu Huo, Tao Lu, Dongni Huang, Wenlin Gong, Lu Gan, Yiqun Luo, Zhikun Zhang, Xiyu Liu, Yongxiang Zhao
Formato: article
Lenguaje:EN
Publicado: Nature Publishing Group 2021
Materias:
R
Acceso en línea:https://doaj.org/article/3966e94a00e04700bdb552809b5edfc5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:3966e94a00e04700bdb552809b5edfc5
record_format dspace
spelling oai:doaj.org-article:3966e94a00e04700bdb552809b5edfc52021-12-05T12:07:19ZGeneration of in situ CRISPR-mediated primary and metastatic cancer from monkey liver10.1038/s41392-021-00799-72059-3635https://doaj.org/article/3966e94a00e04700bdb552809b5edfc52021-12-01T00:00:00Zhttps://doi.org/10.1038/s41392-021-00799-7https://doaj.org/toc/2059-3635Abstract Non-human primates (NHPs) represent the most valuable animals for drug discovery. However, the current main challenge remains that the NHP has not yet been used to develop an efficient translational medicine platform simulating human diseases, such as cancer. This study generated an in situ gene-editing approach to induce efficient loss-of-function mutations of Pten and p53 genes for rapid modeling primary and metastatic liver tumors using the CRISPR/Cas9 in the adult cynomolgus monkey. Under ultrasound guidance, the CRISPR/Cas9 was injected into the cynomolgus monkey liver through the intrahepatic portal vein. The results showed that the ultrasound-guided CRISPR/Cas9 resulted in indels of the Pten and p53 genes in seven out of eight monkeys. The best mutation efficiencies for Pten and p53 were up to 74.71% and 74.68%, respectively. Furthermore, the morbidity of primary and extensively metastatic (lung, spleen, lymph nodes) hepatoma in CRISPR-treated monkeys was 87.5%. The ultrasound-guided CRISPR system could have great potential to successfully pursue the desired target genes, thereby reducing possible side effects associated with hitting non-specific off-target genes, and significantly increasing more efficiency as well as higher specificity of in situ gene editing in vivo, which holds promise as a powerful, yet feasible tool, to edit disease genes to build corresponding human disease models in adult NHPs and to greatly accelerate the discovery of new drugs and save economic costs.Liping ZhongYong HuangJian HeNuo YangBanghao XuYun MaJunjie LiuChao TangChengpiao LuoPan WuZongqiang LaiYu HuoTao LuDongni HuangWenlin GongLu GanYiqun LuoZhikun ZhangXiyu LiuYongxiang ZhaoNature Publishing GrouparticleMedicineRBiology (General)QH301-705.5ENSignal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Biology (General)
QH301-705.5
spellingShingle Medicine
R
Biology (General)
QH301-705.5
Liping Zhong
Yong Huang
Jian He
Nuo Yang
Banghao Xu
Yun Ma
Junjie Liu
Chao Tang
Chengpiao Luo
Pan Wu
Zongqiang Lai
Yu Huo
Tao Lu
Dongni Huang
Wenlin Gong
Lu Gan
Yiqun Luo
Zhikun Zhang
Xiyu Liu
Yongxiang Zhao
Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver
description Abstract Non-human primates (NHPs) represent the most valuable animals for drug discovery. However, the current main challenge remains that the NHP has not yet been used to develop an efficient translational medicine platform simulating human diseases, such as cancer. This study generated an in situ gene-editing approach to induce efficient loss-of-function mutations of Pten and p53 genes for rapid modeling primary and metastatic liver tumors using the CRISPR/Cas9 in the adult cynomolgus monkey. Under ultrasound guidance, the CRISPR/Cas9 was injected into the cynomolgus monkey liver through the intrahepatic portal vein. The results showed that the ultrasound-guided CRISPR/Cas9 resulted in indels of the Pten and p53 genes in seven out of eight monkeys. The best mutation efficiencies for Pten and p53 were up to 74.71% and 74.68%, respectively. Furthermore, the morbidity of primary and extensively metastatic (lung, spleen, lymph nodes) hepatoma in CRISPR-treated monkeys was 87.5%. The ultrasound-guided CRISPR system could have great potential to successfully pursue the desired target genes, thereby reducing possible side effects associated with hitting non-specific off-target genes, and significantly increasing more efficiency as well as higher specificity of in situ gene editing in vivo, which holds promise as a powerful, yet feasible tool, to edit disease genes to build corresponding human disease models in adult NHPs and to greatly accelerate the discovery of new drugs and save economic costs.
format article
author Liping Zhong
Yong Huang
Jian He
Nuo Yang
Banghao Xu
Yun Ma
Junjie Liu
Chao Tang
Chengpiao Luo
Pan Wu
Zongqiang Lai
Yu Huo
Tao Lu
Dongni Huang
Wenlin Gong
Lu Gan
Yiqun Luo
Zhikun Zhang
Xiyu Liu
Yongxiang Zhao
author_facet Liping Zhong
Yong Huang
Jian He
Nuo Yang
Banghao Xu
Yun Ma
Junjie Liu
Chao Tang
Chengpiao Luo
Pan Wu
Zongqiang Lai
Yu Huo
Tao Lu
Dongni Huang
Wenlin Gong
Lu Gan
Yiqun Luo
Zhikun Zhang
Xiyu Liu
Yongxiang Zhao
author_sort Liping Zhong
title Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver
title_short Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver
title_full Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver
title_fullStr Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver
title_full_unstemmed Generation of in situ CRISPR-mediated primary and metastatic cancer from monkey liver
title_sort generation of in situ crispr-mediated primary and metastatic cancer from monkey liver
publisher Nature Publishing Group
publishDate 2021
url https://doaj.org/article/3966e94a00e04700bdb552809b5edfc5
work_keys_str_mv AT lipingzhong generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT yonghuang generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT jianhe generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT nuoyang generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT banghaoxu generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT yunma generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT junjieliu generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT chaotang generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT chengpiaoluo generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT panwu generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT zongqianglai generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT yuhuo generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT taolu generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT dongnihuang generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT wenlingong generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT lugan generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT yiqunluo generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT zhikunzhang generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT xiyuliu generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
AT yongxiangzhao generationofinsitucrisprmediatedprimaryandmetastaticcancerfrommonkeyliver
_version_ 1718372247504158720